Patents by Inventor Jane R. Parnes

Jane R. Parnes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF ATOPIC DERMATITIS WITH ANTI-TSLP ANTIBODY
    Publication number: 20230073888
    Abstract: The present disclosure, relates, in general, to methods of treating atopic dermatitis, including moderate or severe atopic dermatitis, and chronic atopic dermatitis, using an antibody specific for thymic stromal lymphopoietin (TSLP).
    Type: Application
    Filed: February 12, 2021
    Publication date: March 9, 2023
    Inventors: Jane R. Parnes, Steven Komjathy
  • Assay for detecting TH1 and TH2 cell populations
    Patent number: 11156600
    Abstract: The present disclosure relates to a method for detecting T helper cell or CTL subpopulations in a subject affected by disease or disorder having an immune component. The methods are also useful for determining efficacy of a treatment of the disease or disorder by detecting skewing of the T helper cells and CTLs in a therapeutic or adverse direction.
    Type: Grant
    Filed: December 17, 2018
    Date of Patent: October 26, 2021
    Assignee: AMGEN INC.
    Inventors: Kevin Gorski, Jane R. Parnes, Jeannette Bigler, Michael J. Boedigheimer, Andrew A. Welcher
  • TREATMENT OF ASTHMA WITH ANTI-TSLP ANTIBODY
    Publication number: 20210052726
    Abstract: The present disclosure, relates, in general, to methods of treating asthma, including severe asthma and eosinophilic asthma, using an antibody specific for thymic stromal lymphopoietin (TSLP).
    Type: Application
    Filed: November 9, 2020
    Publication date: February 25, 2021
    Inventors: Jane R. Parnes, Janet Griffiths
  • Treatment of asthma with anti-TSLP antibody
    Patent number: 10828365
    Abstract: The present disclosure, relates, in general, to methods of treating asthma, including severe asthma and eosinophilic asthma, using an antibody specific for thymic stromal lymphopoietin (TSLP).
    Type: Grant
    Filed: April 12, 2018
    Date of Patent: November 10, 2020
    Assignee: AMGEN INC.
    Inventors: Jane R. Parnes, Janet Griffiths
  • Assay for Detecting TH1 and TH2 Cell Populations
    Publication number: 20190219563
    Abstract: The present disclosure relates to a method for detecting T helper cell or CTL subpopulations in a subject affected by disease or disorder having an immune component. The methods are also useful for determining efficacy of a treatment of the disease or disorder by detecting skewing of the T helper cells and CTLs in a therapeutic or adverse direction.
    Type: Application
    Filed: December 17, 2018
    Publication date: July 18, 2019
    Inventors: Kevin Gorski, Jane R. Parnes, Jeannette Bigler, Michael J. Boedigheimer, Andrew A. Welcher
  • Assay for detecting Th1 and Th2 cell populations
    Patent number: 10156562
    Abstract: The present disclosure relates to a method for detecting T helper cell or CTL subpopulations in a subject affected by disease or disorder having an immune component. The methods are also useful for determining efficacy of a treatment of the disease or disorder by detecting skewing of the T helper cells and CTLs in a therapeutic or adverse direction.
    Type: Grant
    Filed: May 15, 2015
    Date of Patent: December 18, 2018
    Assignee: AMGEN INC.
    Inventors: Kevin Gorski, Jane R. Parnes, Jeannette Bigler, Michael J. Boedigheimer, Andrew A. Welcher
  • Treatment of Asthma With Anti-TSLP Antibody
    Publication number: 20180296669
    Abstract: The present disclosure, relates, in general, to methods of treating asthma, including severe asthma and eosinophilic asthma, using an antibody specific for thymic stromal lymphopoietin (TSLP).
    Type: Application
    Filed: April 12, 2018
    Publication date: October 18, 2018
    Inventors: Jane R. Parnes, Janet Griffiths
  • Assay for Detecting TH1 and TH2 Cell Populations
    Publication number: 20170082608
    Abstract: The present disclosure relates to a method for detecting T helper cell or CTL subpopulations in a subject affected by disease or disorder having an immune component. The methods are also useful for determining efficacy of a treatment of the disease or disorder by detecting skewing of the T helper cells and CTLs in a therapeutic or adverse direction.
    Type: Application
    Filed: May 15, 2015
    Publication date: March 23, 2017
    Inventors: Kevin Gorski, Jane R. Parnes, Jeanette Bigler, Michael J. Boedigheimer, Andrew A. Welcher